BioCircuit Technologies

About:

BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control, and repair peripheral nerves.

Website: https://www.biocircuit.com/

Top Investors: National Institutes of Health, Alsora Capital, GRA Venture Fund, Michael W. Masters

Description:

BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control and repair peripheral nerves. ​ BioCircuit’s products provide clinicians with a practical ability to diagnose health conditions earlier, track the progression of symptoms over time, and select treatments more precisely for individual patients.

Total Funding Amount:

$15.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Atlanta, Georgia, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)biocircuit.com

Founders:

James Ross

Number of Employees:

11-50

Last Funding Date:

2024-11-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai